David Bellini to Neoplasms
This is a "connection" page, showing publications David Bellini has written about Neoplasms.
Connection Strength
0.106
-
Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy. PLoS One. 2022; 17(3):e0264822.
Score: 0.069
-
Dual-energy CT: oncologic applications. AJR Am J Roentgenol. 2012 Nov; 199(5 Suppl):S98-S105.
Score: 0.036